---
figid: PMC9615186__12943_2022_1668_Fig1_HTML
figtitle: 'Antioxidants in brain tumors: current therapeutic significance and future
  prospects'
organisms:
- Saccharomyces cerevisiae
- Solanum tuberosum
- Curcuma longa
- Allium sativum
- Daucus carota
- Gossypium hirsutum
- Vicia faba
- Corchorus capsularis
- Kaempferia galanga
- Dioscorea alata
- Corchorus olitorius
- Ipomoea aquatica
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9615186
filename: 12943_2022_1668_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9615186/figure/Fig1/
number: F1
caption: Oxidative stress and redox pathway in normal (above) and cancer cells (below).
  ROS regulate several signaling events by regulating the transcriptions of different
  genes in a hypoxic microenvironment that regulate the cell cycle, proliferation,
  and apoptosis. ROS endorse lipid peroxidation, promote electron leakage, and trigger
  Ca2+ release from intracellular stores. ROS in moderate concentrations activate
  oncogenes and suppress tumor suppressor genes that in turn increase ROS concentration.
  Intracellular free Ca2+ triggers PKC activation that promotes proliferation. OS
  also endorses antioxidant genes, promotes angiogenesis, and triggers DNA mutation.
  In addition, ROS induce HDACs that activate oncogenes and inhibit tumor suppressor
  genes through epigenetic regulation. Red arrows indicate downstream events and red
  lines indicate inhibition. Akt, protein kinase B; HDACs, histone deacetylases; HIF-1α,
  hypoxia-inducible factor 1-alpha; IҡBα, nuclear factor of kappa light polypeptide
  gene enhancer in B-cells inhibitor, alpha; MAPKs, mitogen-activated protein kinases;
  NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; Nrf-2, nuclear
  factor erythroid 2-related factor 2; OXO, oxalate oxidase; PI3K, phosphoinositide
  3-kinases; PKC, protein kinase C; PTEN, phosphatase and tensin homolog; ROS, reactive
  oxygen species; TS genes, tumor suppressor genes
papertitle: 'Antioxidants in brain tumors: current therapeutic significance and future
  prospects.'
reftext: Xuchen Qi, et al. Mol Cancer. 2022;21:204.
year: '2022'
doi: 10.1186/s12943-022-01668-9
journal_title: Molecular Cancer
journal_nlm_ta: Mol Cancer
publisher_name: BioMed Central
keywords: Antioxidant | Brain tumor | Chemopreventive role | Chemotherapy | Dietary
  antioxidants | Gene mutation | Glioma | Glioblastoma | Metabolic reprogramming |
  Oxidative stress
automl_pathway: 0.9639081
figid_alias: PMC9615186__F1
figtype: Figure
redirect_from: /figures/PMC9615186__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9615186__12943_2022_1668_Fig1_HTML.html
  '@type': Dataset
  description: Oxidative stress and redox pathway in normal (above) and cancer cells
    (below). ROS regulate several signaling events by regulating the transcriptions
    of different genes in a hypoxic microenvironment that regulate the cell cycle,
    proliferation, and apoptosis. ROS endorse lipid peroxidation, promote electron
    leakage, and trigger Ca2+ release from intracellular stores. ROS in moderate concentrations
    activate oncogenes and suppress tumor suppressor genes that in turn increase ROS
    concentration. Intracellular free Ca2+ triggers PKC activation that promotes proliferation.
    OS also endorses antioxidant genes, promotes angiogenesis, and triggers DNA mutation.
    In addition, ROS induce HDACs that activate oncogenes and inhibit tumor suppressor
    genes through epigenetic regulation. Red arrows indicate downstream events and
    red lines indicate inhibition. Akt, protein kinase B; HDACs, histone deacetylases;
    HIF-1α, hypoxia-inducible factor 1-alpha; IҡBα, nuclear factor of kappa light
    polypeptide gene enhancer in B-cells inhibitor, alpha; MAPKs, mitogen-activated
    protein kinases; NF-κB, nuclear factor kappa-light-chain-enhancer of activated
    B cells; Nrf-2, nuclear factor erythroid 2-related factor 2; OXO, oxalate oxidase;
    PI3K, phosphoinositide 3-kinases; PKC, protein kinase C; PTEN, phosphatase and
    tensin homolog; ROS, reactive oxygen species; TS genes, tumor suppressor genes
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nfkb1
  - Pten
  - Pik3cg
  - Akt1
  - Hif1a
  - Nfe2l2
  - Tp53
  - Prkcg
  - Pik3r1
  - Trp53
  - NFKB1
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - HIF1A
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - NFE2L2
  - TP53
  - TP63
  - TP73
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - Dif
  - dl
  - Rel
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - sima
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Keap1
  - p53
  - betaTub60D
  - hth
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Ts
---
